Big Investments for Human Microbiome Research

by Tim Sandle    Contributor        Biopharma insight / Biopharma Insights

Disclaimer: All opinions expressed by Contributors are their own and do not represent those of their employers, or BiopharmaTrend.com.
Contributors are fully responsible for assuring they own any required copyright for any content they submit to BiopharmaTrend.com. This website and its owners shall not be liable for neither information and content submitted for publication by Contributors, nor its accuracy.

   13572    Comments 2
Topics: Industry Trends   
Share:   Share in LinkedIn  Share in Reddit  Share in X  Share in Hacker News  Share in Facebook  Send by email

Major companies on the scene include Second Genome, Enterome, and EpiBiome. In addition, several new startups have entered the field. Amongst the most active investors, Global Engage reports, are Seventure Partners, Flagship Pioneering and BioGaia. In fact there are some 120 companies investing in analyzing data relating to the human microbiome. To take one example, companies such as uBiome are developing genomic tests meant to identify and diagnose harmful microbes in the body.

Investments are also huge.  in 2018 that “from 2011 through 2015, venture funding in microbiome firms soared 458.5 percent to $114.5 million, while overall venture investment grew 103.4 percent to $75.29 billion. Last year, microbiome investment has surged again despite a decline in overall venture funding. The $616.9 million raised for microbiome companies to date so far in 2016 is more than all of the venture investment in the microbiome space in 2011 through 2015 combined.”The  the human microbiota, which is the aggregate of microorganisms that resides on or within any of a number of human tissues and biofluids. This includes the skin, mammary glands, placenta, seminal fluid, saliva conjunctiva, gastrointestinal tracts and so on. The organisms include bacteria, archaea, protists, fungi and viruses. The human microbiome is a definition beyond the ‘microbiota’, referring to the collective genomes of resident microorganisms.

Continue reading

This content available exclusively for BPT Mebmers

Topics: Industry Trends   

Share:   Share in LinkedIn  Share in Reddit  Share in X  Share in Hacker News  Share in Facebook  Send by email

You may also be interested to read:

 

Comments:

  • Victor Grayson 2019-04-27 11:56

    Fascinating read, this is an emerging area of research.

    reply
    • BiopharmaTrend 2019-04-27 12:08

      Thank you for your feedback, Victor Grayson

      reply

Leave a Reply

Your email address will not be published. Required fields are marked *